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Abstract  
The objective of this study was to evaluate the evidence on whether childhood obesity is a risk factor 
for adult disease, independent of adult body mass index BMI.  Ovid MEDLINE (1948-May 2011), 
EMBASE (1980-2011 Week 18) and the Cochrane Library (1990-2011) were searched for published 
studies of BMI from directly measured weight and height in childhood (2-19 years) and disease 
outcomes in adulthood.  Data were synthesized in a narrative fashion. 39 studies (n 181 – 1.1 million) 
were included in the review.  There was evidence for associations between childhood BMI and type 2 
diabetes (ORs for 1 BMI-SDS ranged 1.22-2.04), hypertension (1.35-3.75) and coronary heart disease 
(1.53-5.43).  Few studies examined associations independent of adult BMI; these showed that effect 
sizes were attenuated after adjustment for adult BMI in standard regression analyses.  Although there 
is a consistent body of evidence for associations between childhood BMI and cardiovascular 
outcomes, there is a lack of evidence for effects independent of adult BMI.  Studies have attempted to 
examine independent effects using standard adjustment for adult BMI, which is subject to 
overadjustment and problems with interpretation. Studies that use more robust designs and analytical 
techniques are needed to establish whether childhood obesity is an independent risk factor for adult 
disease.
Introduction 
Overweight and obesity in adulthood are associated with multiple co-morbidities, most notably type 2 
diabetes, cardiovascular disease, and a number of cancers. 1-2  Dramatic rises in childhood obesity 
prevalence over the last 30 years 3 have brought increasing attention to the potential long-term health 
consequences of childhood obesity.    However, our understanding of the associations of childhood 
obesity with long-term health is incomplete. In particular,  due to the tracking of adiposity from 
childhood into later life, 4 it remains unclear whether childhood obesity has an effect on adult health 
that is independent of adult weight status. Previous reviews have examined the relationship between 
childhood obesity and morbidity in adulthood, 5 but have not considered whether the effects of 
childhood adiposity are independent of adult overweight.  
The objective of this review was to systematically evaluate the current evidence on the contribution of 
childhood body mass index (BMI) to adult disease risk, independent of adult BMI.  We paid particular 
attention to the methods used to assess these independent effects, and considered the strengths and 
limitations of these approaches.  
Methods 
We reviewed published studies investigating the associations between childhood BMI status and 
morbidity and mortality in adulthood, focusing on the methods used to assess independent 
associations.  The outcomes of interest (type 2 diabetes, hypertension, coronary heart disease and 
stroke, asthma, osteoarthritis, gall bladder disease, cancers, and mortality) were selected based on 
previous reviews of the literature. 6   
Ovid MEDLINE (1948-May 2011), EMBASE (1980-2011 Week 18) and the Cochrane Library 
(1990-2011) were searched electronically for relevant publications. Reference lists from selected 
articles were hand-searched for additional studies.  
Search terms used in MEDLINE were: 1. exp Child/ 2. exp Adolescent/ 3. juvenile 4. exp Infant/ 5. 
child$ 6. adolescen$ 7. infan$ 8. teen$ 9. P?ediatric$ 10. Pediatrics/ 11. or/1-10. 12. obes$ or obesity 
13. exp Obesity/ 14. exp Overweight/ or exp Body Weight/ 15. BMI or body mass index or body-
mass-index or weight-for-height 16. exp Body Mass Index/ 17. or/12-16. 18.asthm$ or respiratory 
condition or exp Asthma/ 19. exp Hypertension/ or hypertension 20. cardiovascular disease or exp 
Cardiovascular Diseases/ 21. exp Diabetes Mellitus, Type 2/ or type 2 diabetes 22. osteoarthritis or 
exp Osteoarthritis/ 23. gall bladder disease or exp Gallbladder Diseases/ 24. cancer or exp Neoplasms/ 
25. or/18-24. 26. exp Case-Control Studies/ 27. exp Cohort Studies/ 28. case control 29. cohort adj 
(study or studies) 30. Cohort analy$ 31. Follow up adj (study or studies) 32. observational adj (study 
or studies) 33. Longitudinal 34. Retrospective 35. or/26-34. 36. 11 and 17 and 25 and 35.  
Inclusion criteria:  1) Cohort or case-control designs (exposure and outcomes measured in the same 
individuals), 2) BMI from directly measured weight and height at one or more ages in childhood 
(mean age 2-12 years) or adolescence (13-19 years), 3) Childhood BMI status calculated using 
national or IOTF criteria, 7 or BMI treated as a continuous measure, 4) Any of the outcomes of 
interest assessed in adulthood (≥19 years); and, 5) English language articles published after 1980.  
Exclusion criteria: 1) Participants recruited for an obesity or health promotion intervention, 2) 
Participants from select clinical populations, e.g. preterm babies, childhood cancer survivors, 3) BMI 
from parent or self-reported height and weight in childhood; and, 4) Reporting of risk factors but no 
disease end-point, e.g. blood pressure but not hypertension. Abstracts were double screened (MHP 
and CF) for retrieval of full-text articles, and inter-rater agreement was assessed using kappa 
coefficients (κ). 8   
Data were double-extracted by MHP and CF using a pre-designed form.  The principal outcomes were 
measures of the association of adult disease risk with childhood BMI (regression or correlation 
coefficients) or BMI category/status (risk ratio, hazard ratio or odds ratio and confidence intervals), 
and these measures after accounting for adult BMI.  Quality of observational studies was assessed for 
selection bias, comparability, measurement of outcomes, and adequacy of follow-up using a checklist 
adapted from the Newcastle-Ottawa Scale. Due to the diverse nature of outcomes, study designs and 
effect measures included in the selected studies, data were synthesised and presented in a narrative 
fashion.  We evaluated the methods used to assess independent effects, and summarised their 
strengths and limitations.  Publication bias was assessed using a funnel-plot in Stata 12. To assess 
potential measurement bias, results of studies using self-reported disease were compared with those 
using objective measures.   
Results 
The initial search yielded 7,890 results (Error! Reference source not found.).    A total of 39 studies were included in the 
review; two of these were case-control studies, 9-10 and the remaining were cohort studies.  Inter-rater agreement was 
substantial (84%, κ=0.62).  Sample sizes n ranged from 181 11 to 1.1 million 12.  The majority of studies were from 
Western Europe (Denmark, Finland, Norway, Sweden, the UK, the Netherlands), and the US (including Hawaii).  
Two studies were conducted in Australia, 13-14 and two in Israel. 15-16  Mean ages at BMI measurement ranged from 
birth to 19 years. Full descriptions of included studies can be seen in 
Table 1.  Excluded studies are listed in Table S1. 
Of the 39 included studies, ten reported on type 2 diabetes, five on hypertension, 15 on coronary heart disease (CHD), eight on stroke, two on asthma, three on cancers, two on colon 
cancer, one on kidney cancer, four on breast cancer, one on cervical cancer, one on ovarian cancer, and six on all-cause mortality.  Associations between childhood BMI and adult 
disease outcomes are summarised by outcome in 
Table 2.   
Type 2 diabetes  
There was consistent evidence that overweight in early life was associated with increased risk of type 
2 diabetes in adulthood.  Of 10 studies that analysed the relationship between BMI or BMI status in 
childhood (ages 0-18 years) and type 2 diabetes in adulthood, 9 reported a positive association (n 
ranged from 822 17 to 37,674 16).  Odds ratios for one unit increase in BMI-SDS ranged from 1.22 
(95% CI 1.10 to 1.36) at school entry  (n 5,793), 18  to 2.04 (1.7 to 2.4) at age 16 (n 10,683). 19 One US 
study (n 181) found no evidence of an association between overweight at age 13-18 and diabetes at 
age 73. 11   
When six studies using objectively assessed type 2 diabetes  16-17, 20-23 were considered separately from 
those using self-reported data, all showed that increased BMI or overweight were associated with 
increased risk of type 2 diabetes in adulthood.   
Three of the studies examined the effects of childhood obesity independent of adult BMI by adjusting 
for adult BMI in regression analyses.  In a British cohort, associations between BMI-SDS in 
childhood and adolescence and self-reported type 2 diabetes at age 41 were attenuated to the null after 
adjustment for BMI at age 23 (n 10,683).19  For example, the odds ratio for one unit increase in BMI-
SDS at age 11 was reduced from 1.78 (95% CI 1.5 to 2.1) to 1.06 (0.8 to 1.3).  Similarly, in a study of 
BMI z-score at primary school entry and self-reported diabetes at age 46-50, OR per BMI-SDS at 
school entry decreased from 1.22 (95% CI 1.10 to 1.36) to 1.07 (0.96 to 1.19) after adjustment for 
adult BMI (n 5,793).18   The same effect was observed in an Israeli study; the HR for incident diabetes 
in adulthood was reduced from 2.76 (95% CI 2.12 to 3.58) to 1.01 (0.75 to 1.4) after the inclusion of 
BMI in adulthood in the regression model (n 37,674). 16 
Hypertension 
Five studies reported on hypertension (n from 286 24 to 18,513 15); all used an objective measure of 
hypertension as the outcome, and showed that increased BMI or overweight in early life (ages 1-19) 
was associated with increased risk of hypertension in adulthood (18-45 years).  Odds ratios for obesity 
in childhood ranged from 1.35 (95% CI 1.13 to 1.64) 25 at age 7 to 3.75 (3.45 to 4.07) at age 16-19 y. 
15   
Two of the five studies reported findings adjusted for adult BMI.  In one study, individuals who had 
been overweight at age 8-15 years had five times the risk of hypertension in early adulthood 
compared to those who were normal weight (OR 5.1, 95% CI 1.4, 18.1); after adjustment for BMI at 
age 18-26, the effect size remained the same, but the confidence interval was wider and included 
OR=1. 24  In the other study, associations between BMI-SDS at ages 7, 11, and 16 and clinically 
assessed hypertension at age 45 were no longer observed after controlling for BMI at age 45 years. 25 
Coronary heart disease  
15 studies explored the relationship between BMI in childhood and objective measures of CHD 
events.  Of these, 10 studies (n ranged from 2,990 26 to 1,145,467 12) reported that increased BMI or 
overweight at ages 2-25 years was associated with increased risk of CHD in later life; half of these 
studies were in male study populations. 12, 16, 27-29 Hazard ratios ranged from 1.53 for CHD mortality 
associated with high BMI at age 11 28 to 5.43 (95% CI 2.77 to 10.62) for incident CHD associated 
with high BMI at age 17. 16  In one US study (n 181), higher BMI at ages 13-18 was associated with 
increased risk of CHD morbidity and mortality in males but not females. 11  The remaining studies 
found no association between BMI at age 2-22 years and CHD.   
Two of the studies of CHD looked at the independent effect of childhood obesity.  In one study (n 
37,674), the hazard ratio for incident CHD at age 25-45 for men with BMI in the top decile at age 17 
(compared to the bottom decile) increased from 5.43 (95% CI 2.77 to 10.62) to 6.85 (3.3 to 14.2) after 
adjustment for BMI in adulthood. 16  Another study (n 181), which reported an association between 
overweight in adolescence and CHD mortality among men, found that this association was attenuated 
to the null after adjustment for adult BMI. 11 
Stroke 
Of the 8 studies that reported on objectively measured stroke outcomes, two Swedish studies (n 
46,156 29 and 1,145,467 12) showed that overweight in late adolescence (ages 16-25) was associated 
with increased risk of stroke at ages 39-55.  HRs ranged from 1.4 (95% CI 1.3 to 1.5) for overweight 
to 3.2 (2.4 to 4.3) for very obese children.  A Norwegian study (n 226,678) reported an association 
between high BMI at age 14-19 and stroke mortality in males (RR 1.9, 95% CI 1.2 to 3.2) at ages up 
to 62 years 30; a further study (n 181) observed this association in males. 11  One Finnish study (n 
12,439) reported an inverse relationship. 31  Three British studies (n 2,990 26 to 14,56132) found no 
evidence of an association between childhood BMI and stroke.     
One small study (n 181), which reported an association between overweight in adolescence and stroke 
mortality, found that adjusting for adult BMI attenuated this effect to the null. 11 
Asthma 
Two studies focused on self-reported asthma as an outcome.  One Australian study (n 753) showed 
that overweight at age 7 was associated with OR 3.1 (95% CI 1.3 to 7.3) for adult-onset asthma in 
women. 14 Analysis of a British cohort (n 6,420) found no association between overweight at age 10 
and asthma at age 26. 33   
In the Australian study, the odds ratio was attenuated from 3.1 to 2.13 after adjustment for BMI in 
adulthood, and the 95% confidence interval included OR=1 (0.82 to 5.57). 14 
Cancer 
Three studies reported on cancers from registry data; one study (n 2,347) showed that cohort members 
with BMI-SDS in the highest quartile at age 2-14 years had a 40% increase in risk of cancer. 34  In a 
Norwegian cohort, very high BMI at age 14-19 was associated with a 20% increase in risk of cancer 
mortality among women only. 30  Analysis of data from 78,612 Dutch men showed no association 
between BMI at age 18 and cancer mortality at ages 18-49. 27   
Colorectal cancer mortality was associated with adolescent BMI (ages 13-19) in two studies (RR 2.1 
to 9.1). 11, 30  In a Norwegian study (n 227, 221) high BMI at ages 14-19 was associated with kidney 
cancer among men (RR 2.6, 95% CI 1.5 to 4.7). 35  Of four publications that looked at breast cancer 
outcomes from registry data, one study of 117,415 Danish women showed that increased BMI at age 
14 years was associated with a reduction in risk of breast cancer in adulthood (RR 0.97, 95% CI 0.96 
to 0.98). 36 A case-control study of >10,000 women reported that the risk of pre-menopausal cancer 
was lower among women who were obese at age 18 (RR 0.6, 0.2 to 0.9), but there was no association 
with post-menopausal cases. 9  The other studies found no evidence of an association.  One study 
analysing cervical cancer mortality among Norwegian women showed that very high BMI at ages 14-
19 was associated with RR 1.9, 95% CI 1.1 to 3.2, 30 while a study of ovarian cancer in 111,883 
women showed that high BMI at ages 14-19 was associated with 43-56% increase in risk of ovarian 
tumour. 37  
Two studies of cancer outcomes examined the independent effect of childhood BMI.  The US study 
which showed that adolescent overweight was associated with colorectal cancer mortality reported 
wide confidence intervals for the hazard ratio (n 181), which included HR=1 after adjustment for 
adult BMI. 11 The case-control study of breast cancer 9 showed that women who were overweight at 
age 18, regardless of weight status in adulthood, did not have any difference in risk of pre- or post-
menopausal breast cancer compared to those who were not overweight at age 18 or adulthood.  
All-cause mortality 
Six of the included studies reported on the relationship between BMI status in early life and all-cause 
mortality.  Two studies from Norway (n 226, 678 30 and 227,003 38), one from Sweden (n 45,884 
men), 39 one from the US (n 13,146), 40 and another from Britain (n 2,990) 26 showed that high BMI at 
ages 2-19 was associated with 40-60% increase in risk of all-cause mortality in adulthood.   
In a small US cohort (n 181), an association was observed among men but not women 11; when this 
estimated was adjusted for adult BMI, there was no longer any strong evidence for an association.   
Discussion 
This review has shown that there is a consistent body of evidence for associations between childhood 
overweight, unadjusted for adult BMI, and cardiovascular outcomes and mortality in adulthood.  
However, few studies have assessed the independent effects of childhood overweight on adult disease, 
and the results of these have been inconclusive.  
The finding that childhood overweight is associated with type 2 diabetes, hypertension, coronary heart 
disease, and mortality, unadjusted for adult BMI, is in line with a recently updated systematic review 
of overweight in childhood and mortality and adult morbidity. 5  Evidence for stroke outcomes is 
mixed.  A systematic review which explored the relationship between childhood obesity and asthma 
in adolescence concluded that obesity precedes, and is associated with, asthma 41; however, based on 
the two studies included in this review, there is no strong evidence for an effect of childhood BMI on 
adult-onset asthma.  There is limited evidence that childhood BMI is associated with increased risk of 
colorectal and kidney cancers.  Three of four studies found no association between overweight in 
youth and breast cancer; one study showed that higher BMI in adolescence was associated with 
reduced risk of breast cancer, 36 as has been observed in studies using BMI from recalled height and 
weight in adolescence. 42-43 High BMI in adolescence may be associated with cervical and ovarian 
cancers; however pooled analysis of data from six cohorts with recalled weight at age 18 or 20 found 
no association between BMI in early adulthood and ovarian cancer risk. 44 Inspection of a funnel-plot 
using effect sizes unadjusted for adult BMI revealed asymmetry, indicating the possible presence of 
publication bias.   
This study has expanded on previous reviews 5 by assessing the evidence for the effects of childhood 
overweight on adult disease, independent of adult BMI.  A handful of studies have attempted to 
examine these independent effects by using standard adjustment for BMI or overweight in adulthood; 
most of these have shown that effect sizes were attenuated after adjustment.  The results of these 
analyses are generally interpreted as evidence that unadjusted associations between childhood 
overweight and adult disease risk can be accounted for by adult BMI, and that childhood BMI has no 
underlying effect on disease risk.  However, adjusting for adult BMI in this way has methodological 
limitations.  One problem is that adult BMI is likely to be on the causal path from childhood BMI to 
later disease; adjustment for adult BMI is likely to introduce overadjustment biases, which tend to pull 
effect estimates towards the null. 45  An effect called the ‘reversal paradox’ has been described in the 
literature, in which adjustment for variables on the causal pathway lead to artifactual associations 
between exposures and outcomes. 46-47  Using simulations, Tu et al, 47 showed that a genuine positive 
association between birth weight and adult blood pressure could be attenuated after adjusting for 
current weight, and could even be reversed if correlations between variables were increased.  Given 
the correlation between BMI in early and later life, particularly in those studies with closely spaced 
measurements, these effects are likely to be relevant to the study of childhood overweight and adult 
disease.  Another issue with standard adjustment lies in the interpretation of results 48-49; adjustment 
for adult BMI controls for adult body size, but also effectively adjusts for change in relative size 
between measurements, therefore this approach does not elucidate whether it is early life BMI or BMI 
gain which is associated with the outcome. 49 It is therefore difficult to conclude that childhood 
overweight has long-term effects on health based on the results of standard analyses. 
A limitation of this review is that most of the included studies were conducted in Western Europe and 
North America, limiting the generalisability of our findings.  Expansion of the search to include non-
English language publications may have yielded studies from different settings. A wider limitation 
concerns the generalisability of evidence from cohorts which observe children who were living 
several decades ago.  Contemporary child populations are experiencing more extreme obesity, 50 and 
children are becoming obese at younger ages than in previous generations. 51 The effects of these 
characteristics of the obesity epidemic on long-term health cannot reliably be ascertained from studies 
of older cohorts, who are likely to have different characteristics and environments.  Still, studying 
cohorts with long-term follow-up offers an expedient way of empirically assessing the long-term 
outcomes of childhood exposures.  The findings of such studies are informative where we can 
reasonably assume that pathways to disease will not change dramatically across generations.   
Given the high and rising prevalence of childhood overweight in all parts of the world, it is important 
to know whether childhood obesity has long-term effects on health. This review was unable to 
confirm the presence of long term health effects of childhood obesity, acting independently of its 
effects on adult BMI.  It is conceivable that such effects exist but could not be detected in these 
studies due to limitations in statistical analysis and study design. The limitations in statistical analysis 
attributable to standard adjustments for adult BMI (explained above) could partially be addressed by 
more sophisticated statistical techniques (e.g. structural equation modelling 52 and multilevel 
modelling 53) or alternative approaches to analyses developed specifically for use in life-course 
analyses (e.g.by analysis of different combinations of overweight over the life course 54-55).  However, 
given the high levels of correlatedness inherent in life-course data within cohort designs, more robust 
experimental designs may prove necessary to provide convincing evidence. True randomized trials 
may not be feasible because of a current lack of effective weight loss interventions and the need for 
long term follow up, but other pragmatic study designs (e.g. natural experiments, mendelian 
randomization) may be informative in the meantime. If it was found that childhood obesity had a 
direct effect on long term health, this would place a strong imperative on prevention and early 
treatment in childhood.    
If on the other hand, more robust evidence failed to substantiate an independent effect of childhood 
obesity on adult health, this could indicate that the observed association is mediated entirely through 
adult obesity, or alternatively, that both childhood obesity and adult disease are shared consequences 
of risk factors operating from early life. There is evidence to suggest that certain patterns of growth, 
particularly the combination of small size at birth and catch-up growth in later life, are associated with 
changes in body composition (increased adiposity and reduced lean mass 56-58), and increased disease 
risk in later life. 59-61 Prenatal and postnatal exposures which manifest as growth patterns in early life 
may therefore be linked to structural and functional changes which program future disease risk. 59   
Childhood obesity, measured using a summary measure such as BMI at a single stage of development, 
reflects only one aspect of body size, and in isolation does not capture the dynamic processes of 
growth over the life course which may have important implications for long-term health.  Studies of 
childhood obesity and long-term health must be interpreted in light of these considerations.  
At first glance, a lack of evidence for independent effects of childhood obesity might suggest that 
treating obesity in adulthood would be sufficient for reducing the excess health risk associated with it. 
However, given the intractable nature of established obesity and the emerging evidence on the 
potential biological and early developmental bases underlying this, promotion of healthy weight and 
the prevention of weight accumulation at all stages of the life-course is likely to prove the most 
effective option for individuals and from a policy perspective.   
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 Table and figure legends 
Figure 1: Flow diagram of study selection process, from initial search to included studies 
Table 1: Description of included studies, detailing the main exposures, outcomes, ages at 
measurement and main findings of each study included in the review 
Table 2: Summary of included studies, detailing the available evidence for each disease outcome 
Table 1: Description of included studies 
Reference 
(study design) 
Exposure 
measure(s) 
Disease outcome(s) Age at last 
follow-up 
Population (n, sex, 
location, birth years) 
Main effect size 
Ahlgren 2004 36 
(cohort) 
BMI quintiles at age 
14 y 
Breast cancer  
(registry data) 
Time to 
event 
117,415 Women in 
Copenhagen, b.1930-75 
Lower BMI at age 14 associated with increased risk of breast cancer: RR per 1 unit 
increase in BMI: 0.97 (95% CI 0.96, 0.98) 
Al Mamun 
2009 13 
(cohort) 
BMI z-score at age 
5 y; overweight & 
obesity (IOTF)  
Type 1 and type 2 
diabetes  
(self report) 
21 2,639 (51% ♀) in 
Australia, b. 1981-84 
1 unit increase in BMI z-score at age 5 associated with 60% increase in odds of diabetes 
(OR 1.61; 95% CI 1.24, 2.09); overweight/obesity vs non-obese: OR 2.60; 1.29, 5.22 
Andersen 2010 
62 
(cohort) 
BMI at age 7 y CHD – nonfatal and 
fatal  
(registry data) 
Time to 
event after 
age 25  
216,771 (49% ♀) 
Copenhagen, b.1936-76 
& Helsinki, b.1924-44 
Each unit increase in BMI at age 7 y associated with ~5-10% increase in odds of CHD 
event, after adjustment for birth weight 
Baker 2007 63 
(cohort) 
 
BMI z-score at age 
7-13 y 
CHD – nonfatal and 
fatal  
(registry data) 
Time to 
event 
276,835 Men & women 
(50% ♀) in 
Copenhagen, Denmark, 
b. 1930-76 
♂: 1 unit increase in BMI z-score associated with 5-17% increased odds of nonfatal 
event, 10-24% increase for fatal event 
♀: 1 unit increase in BMI z-score associated with 2-11% increased odds of nonfatal 
event, 7-23% increase for fatal event 
Barker 2002 20 
(cohort) 
BMI quartiles at age 
11 y 
Type 2 diabetes, 
hypertension, CHD 
(registry) 
20+ 13,517 Men & women 
in Helsinki, b. 1924-44 
ORs for1 unit increase in BMI at age 11 [Adjusted for age and sex]: 
T2DM 1.18 (1.13, 1.23); Hypertension 1.07 (1.04, 1.09); CHD 1.06 (1.03, 1.10)  
Barker 2002b 64 
(cohort) 
BMI Z-scores at 
ages 1-12 y 
Hypertension 
(registry data) 
38-39 6,730 Men & women 
(47% ♀) in Finland, b. 
1934-44 
From age 8, high BMI associated with hypertension; cumulative incidence 13.7% (11.2-
16.2) among men with BMI <16 at age 12 vs 21.1% (18.4-23.8) among men with BMI 
>18 
Bjorge 2004 35 
(cohort) 
BMI categories at 
age 14-19 (medium 
25-74th; high -84th; 
v high ≥85th centile, 
US ref.) 
Kidney cancer 
(registry data) 
Time to 
event; mean 
age 45 y 
227,221 Men & women 
(49% ♀) in Norway, b. 
1943-1950s 
♂: Very high BMI at age 14-19 y associated with 2.6 times risk of renal cancer 
compared to medium BMI category: RR 2.64 (95% CI 1.48, 4.70) 
♀: No evidence of association between BMI category at age 14-19 y and renal cancer 
Bjorge 2008 30 
(cohort) 
BMI categories at 
age 14-19 (medium 
25-74th; high -84th; 
very high ≥85th 
centile, US ref.) 
Mortality: cause-
specific and all-
cause  
(registry data) 
Time to 
event up to 
2005; mean 
age 40 - 43 
y  
226,678 Men & women 
(49% ♀) in Norway, b. 
1943-1950s 
Highest BMI category vs. medium [RR (95% CI)].   
All-cause mortality: ♂: 1.4 (1.3, 1.6); ♀: 1.4 (1.2, 1.5) 
Cancer (all): ♂: 1.2 (0.9, 1.5); ♀: 1.2 (1.1, 1.5) 
Ischemic heart disease: ♂: 2.9 (2.3, 3.6); ♀: 3.7 (2.3, 5.7) 
Cerebrovascular diseases: ♂: 1.9 (1.2, 3.2); ♀: 1.5 (0.9, 2.6) 
Burgess 2007 14 
(cohort) 
BMI z-score 
quartiles at age 7 y; 
overweight and 
obesity (IOTF) vs 
non-obese 
Incident asthma 
[adult-onset: age 
>21 y] (self 
reported) 
32 753 Men & women 
(52% ♀) in Tasmania, 
Australia, b. 1961 
♂: No evidence of association between BMI z-score quartile or overweight at age 7 and 
asthma at age 32  
♀: Each increase in BMI z-score quartile at age 7 associated with OR 1.73 (95% CI 1.17, 
2.17); overweight at age 7 OR 3.05; 1.28, 7.29 
Chu 1991 9 
(case-control) 
Overweight (BMI 
>85th centile) at age 
18 y 
Breast cancer 20-54 4,742 cases; 5,698 
controls. Women in 
USA b. 1926-1962 
No evidence of association between BMI category and post-menopausal breast cancer 
risk; RR pre-menopausal breast cancer for obese women 0.6 (0.2, 0.9), no association 
with overweight 
De Stavola 
2004 65 
(cohort) 
BMI-SDS at ages 2, 
4, 7, 11 and 15 y 
Breast cancer  
(registry data) 
53 2,187 Women in UK, b. 
1946 
No evidence of association between BMI-SDS at any age and breast cancer 
Engeland 2003 
37 
(cohort) 
BMI categories at 
age 14-19 (medium 
25-74th; high -84th; 
v high ≥85th centile, 
US ref.) 
Ovarian tumour  
(registry data) 
Time to 
event, up to 
age 100 y or 
2001 
111,883 Women in 
Norway, b. 1943-61 
Being in high and very high BMI categories in adolescence associated with increased 
risk of ovarian cancer compared with medium BMI category. 
High: RR 1.43 (1.00, 2.04); Very high: RR (1.56 (1.04, 2.32) 
Engeland 2003 
38 (cohort) 
BMI categories at 
age 14-19 (85th-94th, 
≥95th vs. reference 
25th-75th centile) 
All-cause mortality 
(registry data) 
Time to 
event, mean 
31.5 years 
follow-up) 
227,003 men and 
women in Norway, b. 
1948-68 
Obesity (BMI >95th centile) at age 14-19 was associated with increased risk of all-cause 
mortality in adulthood (RR in men 1.82; 95% CI 1.48, 2.43, RR in women 2.03; 95% CI 
1.51, 2.72) 
 
Eriksson 1999 
28 
(cohort) 
BMI categories at 
age 11 (BMI ≤15.5; 
-16.5; -17.5; >17.5) 
CHD deaths 
(registry data) 
Deaths 
during 
1971-95 
3,641 Men in Finland, 
b. 1924-33 
BMI at age 11 positively associated with risk of CHD death. Compared to baseline group 
(BMI≤15.5) at age 11 y: BMI 15.5-16.5: HR=1.28; BMI 16.5-17.5: HR=1.35; BMI 
>17.5: HR=1.53 
Eriksson 2001 
66 
(cohort) 
BMI z-score; BMI 
categories at age 6  
(BMI ≤13.6; -14.2; -
14.8; -15.4; >15.4) 
CHD 
hospitalizations & 
deaths (registry) 
Events 
during 
1971-97 
4,630 Men in Finland, 
b. 1934-44 
No evidence of association between BMI z-score and CHD 
Eriksson 2003a 
21 
(cohort) 
BMI at ages 1-12 y Type 2 diabetes 
(registry data) 
Diagnoses 
1964-98 at 
age >40 y 
8,760 Men & women 
(47% ♀) in Finland, b. 
1934-44 
Cumulative incidence of T2DM positively associated with BMI at each age from 4 years 
onwards 
Falkstedt 2007 
29 
(cohort) 
BMI category in 
late adolescence 
(BMI <18.5; -20.9; 
-22.9; -24.9; -29.9; 
≥30) 
CHD and stroke, 
fatal and nonfatal 
(registry data) 
40-55 46,156 Men in Sweden, 
b. 1949-51 
CHD: BMI ≥30 kg/m2 at age 18-20 years associated with 4 times risk compared to BMI 
18.5-20.9 (HR 4.3; 95% CI 3.1-5.9). Stroke: HR in highest BMI category=2.4 (1.3, 4.5); 
lowest risk in BMI category 21.0-22.9 (HR 0.9; 95% CI 0.7, 1.1). 
Field 2005 24 
(cohort) 
BMI z-scores and 
centiles (US ref.) at 
age 8-15 y 
Hypertension 
(self report of 
medication or 
clinical assessment) 
18-26 286 Men & women in 
Boston USA, b. 1963-
73; results reported for 
male subjects only 
Compared to reference group (BMI <75th centile in childhood) individuals with BMI 
75th-84th centile had 3 times risk of hypertension in adulthood (OR=3.6; 95% CI 0.7, 
18.2); individuals with BMI ≥85th centile had 5 times risk (OR=5.1; 95% CI 1.4, 18.1). 
Forsen 2004 67 
(cohort) 
BMI z-score at age 
11 y 
CHD – hospital 
admissions and 
deaths (registry) 
27-64 4,130 Women in 
Finland, b. 1934-44 
No evidence of association between BMI z-score and CHD risk. Compared to baseline 
group BMI <15.9 kg/m2, HR for CHD among BMI >18.4 was 1.79 (0.89, 3.60).  
Gunnell 1998 26 
(cohort) 
 
BMI categories at 
ages 2-14 (<25th;25-
49th; 50th-75th; >75th 
centile, UK90 ref.) 
Mortality – all 
cause, CVD, IHD, 
stroke 
(registry data) 
Up to July 
31, 1995 
2,990 Men & women 
(51% ♀) in Britain, b. 
1922-37 
BMI in 50-75th centile vs. 25th-49th centile: All cause HR 1.4 (1.1, 1.8), CV HR 1.6 (1.1, 
2.5), IHD HR 2.1 (1.3, 3.6).  
BMI >75th centile vs. 25th-49th centile: All cause HR 1.6 (1.1, 2.3).  No evidence of 
association with stroke mortality. 
Hoffmans 1989 
27 
(cohort) 
BMI at age 18 y and 
BMI categories 
(≤18.9; -19.9; -24.9; 
≥25 kg/m2) 
Mortality – CHD 
and cancer 
(death certificates) 
18-49 (32 
years 
follow-up) 
78,612 Men in the 
Netherlands, b. 1932 
Compared to reference group with BMI 19-19.9 kg/m2 
CHD mortality: BMI 20-24.9 associated with 30% increase in risk (HR 1.31; 1.02, 1.67); 
BMI ≥25 HR 2.42 (1.36, 4.30). 
Cancer mortality: No association with BMI category. 
Hypponen 2003 
19 
(cohort) 
 
BMI-SDS tertiles at 
ages 7, 11, 16, 23 y 
Type 2 diabetes  
(self-reported) 
41 10,683 Men & women 
in Britain, b. 1958 
Compared to ref. group (BMI-SDS in middle tertile): Age 7: Upper tertile OR 3.97 (95% 
CI 1.7, 9.1); 1 unit increase in BMI-SDS OR 1.44 (1.2, 1.7).  Age 11: Upper tertile OR 
3.59 (1.7, 7.5); BMI-SDS OR 1.78 (1.5, 2.1).  Age 16: Upper tertile OR 4.18 (2.1, 8.4); 
BMI-SDS OR 2.04 (1.7, 2.4). 
Israeli 2007 15 
(cohort) 
Overweight (BMI 
25-30 kg/m2) and 
obesity (>30) at 
ages 16.5-19 
Hypertension 
(medical history or 
clinical assessment) 
26-45 18,513 Men in Israel, 
recruited to Israeli 
Defense Forces 1976-96 
Adjusted for age and blood pressure at baseline, compared to normal weight, overweight 
in adolescence associated with hypertension risk (OR 1.75; 95% CI 1.66, 1.86); obesity 
associated with nearly 4 times risk (OR 3.75; 3.45, 4.07). 
Jeffreys 2004 34 
(cohort) 
 
BM-SDS at ages 2-
14 y 
Cancers: All, breast, 
colon, prostate, 
lung; cases and 
mortality (registry) 
Cases up to 
Dec 2001, 
deaths to 
Jan 2003 
2,347 Men & women in 
Britain, b. 1922-37 
All cancers: Compared to lowest BMI-SDS quartile, being in highest quartile associated 
w/ 40% increase in risk (OR 1.43; 95% CI 1.01, 2.04); 1 unit increase in BMI-SDS OR 
1.14 (1.00, 1.29); stronger association w/ cancers related to smoking. No association w/ 
other cancers 
Lawlor 2005 68 
(cohort) 
 
BMI z-score at 
primary school 
entry; BMI z-score 
quartiles; IOTF 
categories 
CHD and stroke 
hospital admissions 
and mortality 
(registry data) 
Follow-up 
began on 
January 1, 
1981  
11,106 Men & women 
in Scotland, b. 1950-56 
For CHD, stroke and CHD/stroke: No evidence of association with BMI z-score quartile 
at school entry; no evidence of association with overweight/obese status. 
Lawlor 2006a 
18 
(cohort) 
BMI z-score at 
primary school 
entry 
Diabetes diagnosis 
at age >20 y (self-
reported) 
46-50 5,793 Men & women in 
UK, b. 1950-56 
(singleton births only) 
Each unit increase in BMI z-score at school entry associated with 22% increase in risk of 
diabetes in adulthood (OR 1.22; 95% CI 1.10, 1.36) 
Lawlor 2006b 
32 
(cohort) 
BMI z-score in 
childhood and 
adolescence; IOTF 
overweight & 
obesity  
IHD and stroke 
(registry data) 
Up to 30 
Nov 2004 
2,586 men&women in 
GB b.1922-37; 1,420 
men b.1936-69; 10,555 
men&women b.1948-68 
Pooled results: no evidence of an association between BMI z-score in childhood and risk 
of mortality from IHD or stroke 
Le Marchand 
1988 10 
(case-control) 
BMI tertiles at age 
<25 y 
Breast cancer 
(registry data) 
29-65 3,208 Women in 
Hawaii, b. 1918-43 
No evidence of association between BMI tertile at age <25 y and breast cancer risk 
Li 2007 25 
(cohort) 
 
BMI-SDS at ages 7, 
11, 16; overweight 
and obesity (IOTF) 
Hypertension 
(clinical assessment 
or medication) 
45 9,297 Men & women 
(50% ♀) in Britain, b. 
1958 
BMI-SDS at all ages positively associated w/ hypertension: Age 7, OR 1.10 (1.04, 1.17); 
Age 11, OR 1.22 (1.15, 1.28); Age 16, OR 1.27 (1.20, 1.34) 
Overweight/obese associated w/ increased risk of hypertension: Age 7, OR 1.35 (1.13, 
1.64); Age 11, OR 1.66 (1.39, 1.97); Age 16, OR 1.96 (1.64, 2.35) 
Magnussen 
2010 22 
(cohort) 
BMI Z-scores at 
ages 9-18 y; 
overweight and 
obesity ( IOTF) 
Type 2 diabetes 
(clinical 
assessment) 
24-41 1,781 Men & women 
(56% ♀) in US & 
Finland 
BMI≥75th centile in childhood RR 3.4 (95% CI 1.8-6.4) [adjustment for other MetS 
components, RR 3.0; 1.6-5.7] 
IOTF overweight/obesity RR 3.4 (1.7-6.8)  
Morrison 2010 
17 
(cohort) 
BMI at age 
12.4±3.3 (Princeton 
Follow-up Study) 
10.0±0.5 (National 
Growth & Health 
Study) 
Type 2 diabetes 
(clinical assessment 
or self-report) 
PFS: 
38.6±3.6 
NGHS: 
19.1±0.7 
PFS: 822 men & 
women (53% ♀) in the 
US b. 1960s 
NGHS: 1,067 women in 
the US 
PFS: BMI in top fifth centile at baseline associated with 4-fold increase in risk of T2DM 
(OR 4.00; 95% CI 1.28, 12.5) 
NGHS: no evidence that BMI at baseline associated with T2DM in stepwise logistic 
regression model 
Must 1992 11 
(cohort) 
BMI categories at 
ages 13-18 y 
(overweight: 
BMI>75th centile; 
lean: 25th - 50th 
centiles, US ref.) 
Mortality; 
Morbidity: CHD, 
angina, diabetes, 
athero-sclerosis, 
stroke, hip fracture, 
cancer, arthritis 
(self-report) 
73±1 181 Men & women 
(55% ♀) in the US, b. 
1914-16 
♀– no evidence of association between overweight in adolescence and mortality 
♂– overweight in adolescence associated with all-cause mortality (HR 1.8; 1.2, 2.7); 
CHD mort. (HR 2.3; 1.4, 4.1); stroke mort. (HR 13.2; 1.6, 108.0); colorectal cancer mort. 
(HR 9.1; 1.1, 77.5) 
No evidence of association between overweight in adolescence and angina, diabetes, 
atherosclerosis, stroke, colorectal cancer or stroke; CHD risk increased in men (HR 2.8; 
1.1, 7.2) 
Neovius 2009 
39 (cohort) 
BMI categories at 
age 16-20 y (under-, 
normal, overweight, 
obese; WHO) 
Mortality (registry 
data) 
Follow-up 
to Sept 2007 
45,884 men in Sweden, 
b. 1949-51 
Overweight (HR 1.33; 95% CI 1.15, 1.53) and obesity (HR 2.14; 95% CI 1.61, 2.85) 
associated with increased risk of death (adjusted for muscular strength, age 
socioeconomic status and smoking). 
Nieto 1992 40 
(cohort) 
Quintiles of relative 
weight derived 
internally at age 5-
18  
Mortality (death 
certificates) 
Follow-up 
to June 
1985 
13,146 men and women 
(50.3% ♀) iu the US, b. 
1915-40 
Relative weight in highest quintile (prepubertal and postpubertal) associated with 
increased risk of mortality (OR 1.5; 95% CI 1.0, 2.4) 
Nguyen 2008 23 
(cohort) 
BMI at ages 4-18 y Type 2 diabetes 
(clinical 
assessment) 
19-44 1,988 Men & women 
(57% ♀) in the US, b. 
late 1950s-1990 
Each unit increase in BMI since childhood associated with increased risk of adult 
diabetes (β 0.09; 0.06, 0.12) 
Osmond 2007 
31 
(cohort) 
BMI at ages 1-11 y Stroke - 
hospitalization or 
death (registry data) 
59-69 12,439 Men & women 
(48% ♀) in Finland 
Each unit increase in BMI associated with reduced risk of all stroke at ages 2 (HR 0.84; 
0.77, 0.92) and 7 y (HR 0.85; 0.76, 0.94) [same pattern with hemorrhagic and thrombotic 
stroke]; no evidence for association with BMI at age 11 y 
Shaheen 1999 
33 
(cohort) 
BMI and BMI 
quintiles at age 10 y 
Asthma in the 
previous year 
(self reported) 
26 6,420 Men & women 
(55% ♀) in Britain, b. 
1970 
BMI at age 10 y not associated with asthma at age 26 y 
Silventoinen 
2009 12 
(cohort) 
BMI categories at 
conscription (under-
, normal, 
overweight, obese, 
very obese; WHO) 
CHD and stroke – 
hospitalization and 
mortality 
(registry data) 
39-44 
(follow-up 
to end 2006) 
 
1,145,467 Men in 
Sweden, b. 1951-76 
Hazard ratios (reference group: normal weight) 
CHD:  Overweight 1.74 (1.64, 1.84); Obese 2.50 (2.22, 2.81); Very obese 3.23 (2.54, 
4.10) 
Stroke: Overweight 1.37 (1.26, 1.47); Obese 2.08 (1.78, 2.42); Very obese 3.20 (2.40, 
4.26) 
Tirosh 2011 16 
(cohort) 
BMI percentile at 
age 17 y 
Type 2 diabetes and 
coronary heart 
disease (clinical) 
25-45 (mean 
age 
30.6±5.3) 
37,674 Men in Israel 
Defense Forces (IDF) 
Medical Corps 
HR for incident diabetes in adulthood for top decile of BMI in adolescence vs bottom 
decile: 2.76 (2.12, 3.58) 
HR for incident CHD: 5.43 (2.77, 10.62) 
♂=male; ♀=female; b.=born; ref.=reference population; BMI=body mass index kg/m2; CHD=coronary heart disease; HR=hazard ratio; OR=odds ratio; RR=risk ratio; 95% 
CI=95% confidence interval; IOTF=International Obesity Task Force definition of childhood overweight/obesity; WHO=World Health Organization definition of 
overweight/obesity 
Table 2: Summary of included studies 
Outcome Number 
of 
studies 
Summary– 
unadjusted for 
adult size 
Summary– 
adjusted for 
adult size 
Description 
Type 2 
diabetes 
10 +++++++++? 
 
??? 
 
9 studies 13, 16-23: increased BMI/overweight in childhood 
and adolescence associated with increased risk  
1 study: no evidence of association 11 
3 studies: adjustment for adult body sizeno association 
Hypertension 5 +++++ 
 
?? 
 
5 studies 11, 15-16, 18, 20, 23-25, 64: increased BMI/overweight in 
childhood/adolescence associated with increased risk  
2 studies: adjustment for adult BMI  no association 
Coronary 
heart disease  
15 ++++++++++???? 
+ (♂)   
 
+? 10 studies 12, 16, 20, 26-30, 62-63: increased BMI/overweight in 
childhood and adolescence associated with increased risk 
of CHD (nonfatal and fatal) in adulthood 
1 study 11: Positive association in men only 
4 studies 32, 66-68: no evidence of association 
1 study: adjustment for adult BMI increased HR 
1 study: adjustment for adult BMI  no association 
Stroke 8 +++ ??? 
+ (♂)   
 
? 
 
 
2 studies 12, 29: increased BMI/overweight  in adolescence 
associated with increased risk of stroke in adulthood 
1 study 30: higher BMI in adolescence associated with 
increased risk of death from cerebrovascular diseases 
1 study 11: positive association in men only 
1 study 31: increased BMI associated with reduced risk 3 
studies 26, 32, 68: no evidence of association 
1 study: adjustment for adult BMI  no association  
Asthma 2 ? 
+ (♀)   
? 
 
1 study 14: increased BMI in childhood associated with 
increased risk of asthma in women only 
1 study 33: no evidence of association  
1 study: adjustment for adult BMI  no association 
All cancers 3 +? 
+ (♀)   
n/a 
 
1 study 34: Higher BMI-SDS in childhood associated with 
increased odds of cancer  (cases and mortality) 
1 study 30: higher BMI in adolescence associated with 
increased risk of cancer mortality in women only 
1 study 27: no evidence of association  
Colon cancer 2 ++ 
 
? 
 
2 studies 11, 30: Higher BMI in adolescence associated 
with increased risk of colorectal cancer mortality 
1 study: adjustment for adult BMI  no association 
Kidney 
cancer 
1 + (♂)   
 
n/a 
 
1 study 35: High BMI in adolescence associated with 
increased risk of renal cancer in boys 
Breast 
cancer 
4 ?? ? 1 study 36: lower BMI at age 14 y associated with 
increased risk; 1 study 9: obesity associated with reduced 
risk of pre-menopausal breast cancer 
2 studies 10, 65: no evidence of association  
1 study: adjustment for adult overweight no association 
Cervical 
cancer 
1 + 
 
n/a 
 
1 study 30: Higher BMI in adolescence associated with 
increased risk of cervical cancer mortality 
Ovarian 
cancer 
1 + 
 
n/a 
 
1 study 37: High BMI in adolescence associated with 
increased risk of ovarian cancer 
All-cause 
mortality 
6 +++++ 
+ (♂)   
? 
 
5 studies 26, 30, 38-40: increased BMI in childhood/ 
adolescence associated with increased risk of mortality 
1 study 11: association in men only 
1 study: adjustment for adult BMI  no association  
+ indicates positive association between BMI/weight status and disease;  indicates negative 
association; ? indicates no association; ♂=male; ♀=female; n/a=not available 
 
